Back to Search
Start Over
Understanding HIV-1 protease autoprocessing for novel therapeutic development
- Source :
- Future medicinal chemistry. 5(11)
- Publication Year :
- 2013
-
Abstract
- In the infected cell, HIV-1 protease (PR) is initially synthesized as part of the GagPol polyprotein. PR autoprocessing is a virus-specific process by which the PR domain embedded in the precursor catalyzes proteolytic reactions responsible for liberation of free mature PRs, which then recognize and cleave at least ten different peptide sequences in the Gag and GagPol polyproteins. Despite extensive structure and function studies of the mature PRs as well as the successful development of ten US FDA-approved catalytic-site inhibitors, the precursor autoprocessing mechanism remains an intriguing yet-to-be-solved puzzle. This article discusses current understanding of the autoprocessing mechanism, in an effort to prompt the development of novel anti-HIV drugs that selectively target precursor autoprocessing.
- Subjects :
- Polyproteins
medicine.medical_treatment
HIV Infections
Biology
Article
HIV-1 protease
HIV Protease
Cleave
Infected cell
Catalytic Domain
Drug Discovery
medicine
HIV Protease Inhibitor
Humans
Amino Acid Sequence
Protein Precursors
Peptide sequence
Pharmacology
Protease
HIV Protease Inhibitors
Virology
Structure and function
biology.protein
HIV-1
Molecular Medicine
Protein Processing, Post-Translational
Subjects
Details
- ISSN :
- 17568927
- Volume :
- 5
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- Future medicinal chemistry
- Accession number :
- edsair.doi.dedup.....76ef51e1d7de2590303a4810e2886d51